URALLNEWS 0 Comments More than 1 billion doses of Covid-19 vaccines has been administered in China, as the country is pushing ahead with the largest vaccination drive in its history, according to the National Health Commission (NHC) on Sunday.
It took the country just five days to hit its most recent 100-million dose increase, Xinhua news agency reported citing the NHC as saying.
China accelerated its pace of free Covid-19 vaccinations for the whole nation since late March.
It took China 25 days to climb from 100 million doses to 200 million doses, 16 days to increase from 200 million to 300 million, and six days from 800 million to 900 million.
A total of 21 vaccines have entered clinical trials in China since last year.
So far, four vaccines have been granted conditional marketing approval and three have been authorised for emergency use within the country.
China’s nationwide vaccination campaign is open to people aged over 18.
The country has approved the emergency use of domestic inactivated vaccines on people aged 3 to 17.
Detailed policies will be formulated for the inoculation of this age group based on the specific Covid situation.
At least 70 per cent of the target population in China is expected to be vaccinated against Covid-19 by the end of this year, according to Zeng Yixin, deputy head of the NHC.
–IANS
ksk/
Â
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader, Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance. We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard .
Digital Editor

This data comes from MediaIntel.Asia's Media Intelligence and Media Monitoring Platform.